{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:58:54Z","timestamp":1782482334319,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Medical and Hygiene Research Projects of the Inner Mongolia Health and Family Planning Commission","award":["201301094"],"award-info":[{"award-number":["201301094"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271900"],"award-info":[{"award-number":["81271900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-2947-6","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T14:18:44Z","timestamp":1516112324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhi-guo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-dong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ri","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-zhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-qing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-nan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu-yun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-zhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"issue":"2","key":"2947_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","volume":"6","author":"G Pappas","year":"2006","unstructured":"Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91\u20139. doi: 10.1016\/S1473-3099(06)70382-6.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2947_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/ijms.8.198","volume":"8","author":"Y Bayram","year":"2011","unstructured":"Bayram Y, Korkoca H, Aypak C, Parlak M, Cikman A, Kilic S, Berktas M. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. Int J Med Sci. 2011;8(3):198\u2013202.","journal-title":"Int J Med Sci"},{"issue":"4","key":"2947_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1128\/AAC.35.4.756","volume":"35","author":"JA Garcia-Rodriguez","year":"1991","unstructured":"Garcia-Rodriguez JA, Garcia SJ, Trujillano I. Lack of effective bactericidal activity of new quinolones against Brucella spp. Antimicrob Agents Chemother. 1991;35(4):756\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2947_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/1471-2180-11-256","volume":"11","author":"H Jiang","year":"2011","unstructured":"Jiang H, Fan M, Chen J, Mi J, Yu R, Zhao H, Piao D, Ke C, Deng X, Tian G, et al. MLVA genotyping of Chinese human Brucella melitensis biovar 1, 2 and 3 isolates. BMC Microbiol. 2011;11:256. doi: 10.1186\/1471-2180-11-256 .","journal-title":"BMC Microbiol"},{"issue":"2","key":"2947_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7603\/s40681-015-0009-6","volume":"5","author":"N Tien","year":"2015","unstructured":"Tien N, Sung YJ, Chang YC, You BJ, Liang M, Lim YP, Ho WY, Lin HS, Ho MW, Ho CM, et al. The medical diagnostic approaches with phylogenetic analysis for rare Brucella spp. diagnosis in Taiwan. Biomedicine (Taipei). 2015;5(2):9. doi: 10.7603\/s40681-015-0009-6 .","journal-title":"Biomedicine (Taipei)"},{"issue":"5","key":"2947_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/cid\/cis980","volume":"56","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang W, Ke Y, Zhen Q, Yuan X, Zou W, Li S, Sun Y, Wang Z, Wang D, et al. Human brucellosis, a heterogeneously distributed, delayed, and misdiagnosed disease in china. Clin Infect Dis. 2013;56(5):750\u20131. doi: 10.1093\/cid\/cis980 .","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2947_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.7150\/ijms.6565","volume":"10","author":"M Parlak","year":"2013","unstructured":"Parlak M, Guducuoglu H, Bayram Y, Cikman A, Aypak C, Kilic S, Berktas M. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods. Int J Med Sci. 2013;10(10):1406\u201311. doi: 10.7150\/ijms.6565 .","journal-title":"Int J Med Sci"},{"issue":"4","key":"2947_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijantimicag.2003.09.024","volume":"23","author":"N Baykam","year":"2004","unstructured":"Baykam N, Esener H, Ergonul O, Eren S, Celikbas AK, Dokuzoguz B. In vitro antimicrobial susceptibility of Brucella species. Int J Antimicrob Agents. 2004;23(4):405\u20137. doi: 10.1016\/j.ijantimicag.2003.09.024 .","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2947_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10156-011-0281-7","volume":"18","author":"M Sayan","year":"2012","unstructured":"Sayan M, Kilic S, Uyanik MH. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. J Infect Chemother. 2012;18(1):41\u20136. doi: 10.1007\/s10156-011-0281-7 .","journal-title":"J Infect Chemother"},{"issue":"7","key":"2947_CR10","doi-asserted-by":"publisher","first-page":"e132532","DOI":"10.1371\/journal.pone.0130868","volume":"10","author":"PR Barbosa","year":"2015","unstructured":"Barbosa PR, Reinato SA, Pinto DSMJ, Seles DE, Alves TM, de Sousa MSM, Minharro S, Heinemann MB, Lage AP. Reduced susceptibility to rifampicin and resistance to multiple antimicrobial agents among Brucella abortus isolates from cattle in Brazil. PLoS One. 2015;10(7):e132532. doi: 10.1371\/journal.pone.0132532 .","journal-title":"PLoS One"},{"issue":"6","key":"2947_CR11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/AAC.43.6.1531","volume":"43","author":"A Kinsara","year":"1999","unstructured":"Kinsara A, Al-Mowallad A, Osoba AO. Increasing resistance of Brucellae to co-trimoxazole. Antimicrob Agents Chemother. 1999;43(6):1531.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"2947_CR12","first-page":"408","volume":"91","author":"AL Olitzky","year":"1976","unstructured":"Olitzky AL. Laboratory techniques in brucellosis. Harefuah. 1976;91(11):408\u20139.","journal-title":"Harefuah"},{"issue":"11","key":"2947_CR13","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JCM.32.11.2660-2666.1994","volume":"32","author":"BJ Bricker","year":"1994","unstructured":"Bricker BJ, Halling SM. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994;32(11):2660\u20136.","journal-title":"J Clin Microbiol"},{"key":"2947_CR14","volume-title":"Methods of antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved guidelines- second edition. CLSI document M45-A2","author":"CLSI","year":"2010","unstructured":"CLSI. Methods of antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved guidelines- second edition. CLSI document M45-A2. Clinical and Laboratory Standard Institute: Wayne; 2010."},{"key":"2947_CR15","volume-title":"Performance standard for antimicrobial susceptibility testing: twentyfourth informational supplement. CLSI document M100-S24","author":"CLSI","year":"2014","unstructured":"CLSI. Performance standard for antimicrobial susceptibility testing: twentyfourth informational supplement. CLSI document M100-S24. Clinical and Laboratory Standard Institute: Wayne; 2014."},{"issue":"12","key":"2947_CR16","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1128\/JCM.42.12.5439-5443.2004","volume":"42","author":"C Marianelli","year":"2004","unstructured":"Marianelli C, Ciuchini F, Tarantino M, Pasquali P, Adone R. Genetic bases of the rifampin resistance phenotype in Brucella spp. J Clin Microbiol. 2004;42(12):5439\u201343. doi: 10.1128\/JCM.42.12.5439-5443.2004 .","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2947_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jac\/dkp389","volume":"65","author":"S Valdezate","year":"2009","unstructured":"Valdezate S, Navarro A, Medina-Pascual MJ, Carrasco G, Sa\u00e9z-Nieto JA. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis. J Antimicrob Chemoth. 2009;65(1):51\u20133.","journal-title":"J Antimicrob Chemoth"},{"key":"2947_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-0711-11-24","volume":"11","author":"M Abdel-Maksoud","year":"2012","unstructured":"Abdel-Maksoud M, House B, Wasfy M, Abdel-Rahman B, Pimentel G, Roushdy G, Dueger E. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Ann Clin Microbiol Antimicrob. 2012;11:24. doi: 10.1186\/1476-0711-11-24 .","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"2947_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/00365540410020767","volume":"36","author":"A Lopez-Merino","year":"2004","unstructured":"Lopez-Merino A, Contreras-Rodriguez A, Migranas-Ortiz R, Orrantia-Gradin R, Hernandez-Oliva GM, Gutierrez-Rubio AT, Cardenosa O. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. Scand J Infect Dis. 2004;36(9):636\u20138. doi: 10.1080\/00365540410020767 .","journal-title":"Scand J Infect Dis"},{"issue":"8","key":"2947_CR20","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1292\/jvms.12-0163","volume":"75","author":"Z Ilhan","year":"2013","unstructured":"Ilhan Z, Solmaz H, Ekin IH. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey. J Vet Med Sci. 2013;75(8):1035\u201340.","journal-title":"J Vet Med Sci"},{"issue":"9","key":"2947_CR21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/039139881003300907","volume":"33","author":"KB Gattringer","year":"2010","unstructured":"Gattringer KB, Suchomel M, Eder M, Lassnigg AM, Graninger W, Presterl E. Time-dependent effects of rifampicin on staphylococcal biofilms. Int J Artif Organs. 2010;33(9):621\u20136.","journal-title":"Int J Artif Organs"},{"key":"2947_CR22","doi-asserted-by":"crossref","unstructured":"Hashim R, Ahmad N, Mohamed ZJ, Tay BY, Mohd NA, Zainal S, Hamzah H, Hamzah SH, Chow TS, Wong PS, et al. Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis. Int J Microbiol. 2014; 2014(596245. doi: 10.1155\/2014\/596245 .","DOI":"10.1155\/2014\/596245"},{"issue":"1","key":"2947_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5339\/qmj.2014.4","volume":"2014","author":"AI Rahil","year":"2014","unstructured":"Rahil AI, Othman M, Ibrahim W, Mohamed MY. Brucellosis in Qatar: a retrospective cohort study. Qatar Med J. 2014;2014(1):25\u201330. doi: 10.5339\/qmj.2014.4 .","journal-title":"Qatar Med J"},{"issue":"12","key":"2947_CR24","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1128\/AAC.38.12.2798","volume":"38","author":"JD Colmenero","year":"1994","unstructured":"Colmenero JD, Fernandez-Gallardo LC, Agundez JA, Sedeno J, Benitez J, Valverde E. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother. 1994;38(12):2798\u2013802.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2947_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ja.2014.107","volume":"67","author":"BP Goldstein","year":"2014","unstructured":"Goldstein BP. Resistance to rifampicin: A review. J Antibiot. 2014;67(9):625\u201330.","journal-title":"J Antibiot"},{"key":"2947_CR26","doi-asserted-by":"crossref","unstructured":"Deshmukh A, Hagen F, Sharabasi OA, Abraham M, Wilson G, Doiphode S, Maslamani MA, Meis JF. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014\u2009\u2013\u20092015. BMC Microbiol. 2015;15(1) doi: 10.1186\/s12866-015-0458-9 .","DOI":"10.1186\/s12866-015-0458-9"},{"issue":"4","key":"2947_CR27","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1021\/pr201122w","volume":"11","author":"V Sandalakis","year":"2012","unstructured":"Sandalakis V, Psaroulaki A, De Bock P, Christidou A, Gevaert K, Tsiotis G, Tselentis Y. Investigation of rifampicin resistance mechanisms in Brucella abortus using MS-driven comparative proteomics. J Proteome Res. 2012;11(4):2374\u201385. doi: 10.1021\/pr201122w .","journal-title":"J Proteome Res"},{"issue":"9","key":"2947_CR28","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1128\/JCM.00135-13","volume":"51","author":"RM Traxler","year":"2013","unstructured":"Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL. A literature review of laboratory-acquired brucellosis. J Clin Microbiol. 2013;51(9):3055\u201362. doi: 10.1128\/JCM.00135-13 .","journal-title":"J Clin Microbiol"},{"issue":"20","key":"2947_CR29","doi-asserted-by":"publisher","first-page":"13148","DOI":"10.1073\/pnas.192319099","volume":"99","author":"IT Paulsen","year":"2002","unstructured":"Paulsen IT, Seshadri R, Nelson KE, Eisen JA, Heidelberg JF, Read TD, Dodson RJ, Umayam L, Brinkac LM, Beanan MJ, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci U S A. 2002;99(20):13148\u201353. doi: 10.1073\/pnas.192319099 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2947_CR30","first-page":"238","volume":"11","author":"GR Irajian","year":"2016","unstructured":"Irajian GR, Masjedian JF, Mirnejad R, Piranfar V, Zahraei ST, Amir MN, Ghaznavi-Rad E, Khormali M, Species-specific PCR. For the diagnosis and determination of antibiotic susceptibilities of Brucella strains isolated from Tehran, Iran. Iran J Pathol. 2016;11(3):238\u201347.","journal-title":"Iran J Pathol"},{"issue":"7","key":"2947_CR31","doi-asserted-by":"publisher","first-page":"e19961","DOI":"10.5812\/jjm.19961v2","volume":"8","author":"H Arabi","year":"2015","unstructured":"Arabi H, Pakzad I, Nasrollahi A, Hosainzadegan H, Azizi JF, Taherikalani M, Samadi N, Monadi SA. Sulfonamide resistance genes (sul) M in extended Spectrum Beta lactamase (ESBL) and non-ESBL producing Escherichia Coli isolated from Iranian hospitals. Jundishapur J Microbiol. 2015;8(7):e19961. doi: 10.5812\/jjm.19961v2.","journal-title":"Jundishapur J Microbiol"},{"issue":"2","key":"2947_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/AAC.39.2.279","volume":"39","author":"P Huovinen","year":"1995","unstructured":"Huovinen P, Sundstr\u00f6m L, Swedberg G, Sk\u00f6ld O. Trimethoprim and sulfonamide resistance. Antimicrobial Agents & Chemotherapy. 1995;39(2):279\u201389.","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"2","key":"2947_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58(2):256\u201365. doi: 10.1093\/jac\/dkl224 .","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2947_CR34","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/AAC.8.6.713","volume":"8","author":"M Barza","year":"1975","unstructured":"Barza M, Brown RB, Shanks C, Gamble C, Weinstein L. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother. 1975;8(6):713\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2947_CR35","first-page":"66","volume":"52","author":"GW Hanson","year":"2009","unstructured":"Hanson GW. Brucellosis in humans and animals. Ceylon Med J. 2009;52(2):66.","journal-title":"Ceylon Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T17:57:49Z","timestamp":1603648669000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-2947-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2947"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-2947-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]},"assertion":[{"value":"11 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"43"}}